Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Zhen-yi Xu"'
Autor:
Ru-Jia Li, Jia-yin Xu, Xue Wang, Li-juan Liao, Xian Wei, Ping Xie, Wen-yan Xu, Zhen-yi Xu, Shuo-hua Xie, Yu-ying Jiang, Liang Huang, Lu-yao Wang, Gan-rong Huang, Yan-Qiang Huang
Publikováno v:
Frontiers in Microbiology, Vol 14 (2023)
Modifying and transforming natural antibacterial products is a novel idea for developing new efficacious compounds. Phillygenin has an inhibitory effect on H. pylori. The aim of the present study was to prepare a phillygenin derivative (PHI-Der) thro
Externí odkaz:
https://doaj.org/article/af2662c701584c1b928de1446578cf31
Autor:
Qing Xi, Ying Chen, Guang-Ze Yang, Jie-You Zhang, Li-Juan Zhang, Xiang-Dong Guo, Jing-Yi Zhao, Zhen-Yi Xue, Yan Li, Rongxin Zhang
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
Pancreatic adenocarcinoma (PDAC) is a highly fatal disease worldwide. MicroRNAs (miRNAs) could regulate the protein-coding RNAs related to tumor growth, invasion, and immune evasion. Therefore, the investigation of novel miRNAs may be helpful in the
Externí odkaz:
https://doaj.org/article/9bd21d55610149fdb94bda0319600991
Publikováno v:
Cancer Biology & Medicine, Vol 8, Iss 4, Pp 207-214 (2011)
Cetuximab is a chimeric immunoglobulin G1 mono-clonal antibody that targets the ligand-binding domain of the epidermal growth factor receptor and inhibits downstream intra- cellular signals. Research has shown that etuximab can stimulate the autoimmu
Externí odkaz:
https://doaj.org/article/09d8ddf3045c411d8a1f31aef887bf27
Autor:
Masuo Hosokawa, Yutaka Sawamura, Kiyoshi Morikawa, Kazuo Itoh, Zhen-Yi Xu, Hiroshi Kobayashi, Toshihiko Morikage, Futoshi Okada
Publikováno v:
Cancer Immunology Immunotherapy. 26
We investigated the combined effects of human recombinant interleukin 2 (IL-2) and cyclophosphamide (CY) on s.c. transplanted 3LL lung carcinoma in C57BL/6 mice. A total of 95% of the tumors were completely cured when CY (150 mg/kg, i.v.) was given o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::24df0489675e9673af712a8eaf0d9b22
https://doi.org/10.1007/bf00199937
https://doi.org/10.1007/bf00199937
Publikováno v:
Cancer Immunology Immunotherapy. 23
We observed that after KMT-17 cells had been treated with bleomycin (BLM), even with a dose as high as 160 micrograms/ml, they were still able to form colonies in soft agar. We then studied the susceptibility of KMT-17 cells treated with BLM to activ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b190b3454454665e0da574d9171b9bf0
https://doi.org/10.1007/bf00205554
https://doi.org/10.1007/bf00205554
Publikováno v:
Cancer Immunology Immunotherapy. 22
We investigated the therapeutic effects of an immunopotentiator PS-K on recurrent or metastatic tumors observed after the surgical removal of MCA-induced primary tumors in autochthonous C57BL/6 mice and on the survival time of treated mice. The MST o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d914447302c5280c0d2aaeae00f7f1a
https://doi.org/10.1007/bf00200030
https://doi.org/10.1007/bf00200030